BDBM416761 (E)-N-[3-[4-amino-7-oxo-3-(4- phenoxyphenyl)-6H-pyrrolo[2,3 d]pyridazin-1-yl]-8- bicyclo[3.2.1]octanyl]-4- (dimethylamino)but-2-enamide::US10323037, Example 48

SMILES CN(C)C\C=C\C(=O)NC1C2CCC1CC(C2)n1cc(-c2ccc(Oc3ccccc3)cc2)c2c(N)n[nH]c(=O)c12

InChI Key InChIKey=WVKMSWKNJPOCRW-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 416761   

TargetTyrosine-protein kinase BTK(Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM416761(US10323037, Example 48 | (E)-N-[3-[4-amino-7-oxo-3...)
Affinity DataIC50: 505nMAssay Description:The Btk kinase assay was performed using a ADP-Glo Btk kinase assay kit purchased from Promega (Madison, Wis.). The assay was conducted according to ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/24/2020
Entry Details
US Patent